Diamonds and Dogs


Novavax (NVAX) jumps 64% to a six-year high Friday after the company reported its experimental coronavirus vaccine was nearly 90% effective in a final-phase test. The experimental, two-shot vaccine was 89.3% effective against Covid-19 in a U.K. study, Novavax's jab was also effective against the U.K. and South Africa variants of the virus that causes Covid-19.

Johnson & Johnson's (JNJ) drops 3% followng thier vaccine news.The J&J vaccine was 72% efficacious in the U.S., though globally the efficacy dropped to 66%. The difference in efficacy shows the gap in effectiveness against strains from South Africa and Brazil. In South Africa, the efficacy dropped to 57%, while in Latin America it was 66% effective. Many doctors hailed this news as a positive, but with Pfizer and Moderna effectiveness over 90%, the markets are not sure how useful the J&J vaccine will be.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.